{"text": ["AKCA", "Up", "33%", "In", "2", "Days,", "AGTC", "Awaits", "XLRS", "Data,", "EYPT", "On", "Watch"], "created_at": "2018-09-25 21:24:00"}
{"text": ["AKCA", "Up", "33%", "In", "2", "Days,", "AGTC", "Awaits", "XLRS", "Data,", "EYPT", "On", "Watch"], "created_at": "2018-09-25 21:24:00"}
{"text": ["AstraZeneca's", "Imfinzi", "Gets", "EU", "Nod", "for", "Early-Stage", "Lung", "Cancer"], "created_at": "2018-09-25 16:57:02"}
{"text": ["AstraZeneca's", "Imfinzi", "Gets", "EU", "Nod", "for", "Early-Stage", "Lung", "Cancer"], "created_at": "2018-09-25 16:57:02"}
{"text": ["USMV,", "PFE,", "WM,", "ACN:", "Large", "Inflows", "Detected", "at", "ETF"], "created_at": "2018-09-25 16:54:49"}
{"text": ["USMV,", "PFE,", "WM,", "ACN:", "Large", "Inflows", "Detected", "at", "ETF"], "created_at": "2018-09-25 16:54:49"}
{"text": ["Allergan\u2019s", "First", "Medical", "Aesthetics", "Innovation", "Center", "in", "China"], "created_at": "2018-09-25 14:32:47"}
{"text": ["AstraZeneca&apos;s", "Imfinzi", "Gets", "EU", "Nod", "for", "Early-Stage", "Lung", "Cancer"], "created_at": "2018-09-25 14:23:02"}
{"text": ["J&J", "Files", "for", "US", "Approval", "of", "Cancer", "Drug", "Erdafitinib"], "created_at": "2018-09-25 13:02:22"}
{"text": ["Factors", "of", "Influence", "in", "2018,", "Key", "Indicators", "and", "Opportunity", "within", "Dorchester", "Minerals,", "Teladoc,", "Pfizer,", "Intercontinental", "Exchange,", "General", "Electric,", "and", "Prospect", "Capital", "\u2014", "New", "Research", "Emphasizes", "Economic", "Growth"], "created_at": "2018-09-25 12:50:00"}
{"text": ["Asian", "Shares", "Mixed", "As", "Investors", "Weigh", "Risks"], "created_at": "2018-09-25 04:28:00"}
{"text": ["Asian", "Shares", "Mixed", "As", "Investors", "Weigh", "Risks"], "created_at": "2018-09-25 04:28:00"}
